The Heal in India announcement may have several pros and wins but being alert to the cons is even more potent. Cognizance of the impact on the overall approach towards the India healthcare model is crucial.
Is India ready to invite the world to ‘Heal in India’ or should it choose to focus on working to empower the nation’s healthcare ecosystem that continues to be crippled by its own shortcomings?, writes our Partner – Sidharrth Shankar in an article titled “Heal in India – The Hits” published in Express Pharma.
Please refer to the below document to read the full article by Sidharrth Shankar, published in Express Pharma.
Click here to download the pdf.
Sidharrth is the Co-Chair of the Corporate Practice at JSA. He specializes in General Corporate Commercial, Mergers & Acquisitions and Private Equity.